Obese diabetes patients gain A1C benefit from bypass liner

10/1/2013 | Medscape (free registration)

A small study presented at the European Association for the Study of Diabetes meeting revealed severely obese type 2 diabetes patients who used EndoBarrier, a duodenal-jejunal bypass liner, showed reduced A1C levels, dropping from 8.5% to 7.5% at one year. In addition, patients reduced their body weight by an average of 10% and experienced improvements in fasting glucose levels and systolic blood pressure.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ